Syrebo recently welcomed an esteemed delegation comprising Prof. Dr. Dirk Vissers and Prof. Dr. Bart Van Rompaey from the University of Antwerp, along with Bart Segers, Head of Department of Physiotherapy and Rehabilitation at ZAS Hospital in Belgium, for an insightful visit to explore cutting-edge rehabilitation technologies.
During their time at Syrebo, the delegation experienced firsthand the capabilities of the company's flagship innovation, the BCI Hand Rehabilitation Robot. The device, powered by advanced brain-computer interface (BCI) technology, has the potential to transform rehabilitation practices and significantly enhance patient outcomes.
As part of their visit, the professors and the department head also toured Shanghai Tongren Hospital, where Syrebo devices have already been successfully implemented in clinical settings. They observed how these technologies are being used to support patients' recovery journeys, gaining valuable insights into their real-world applications.
The visit provided a platform for meaningful exchanges on innovative research ideas and future clinical collaborations, aimed at bridging the gap between academic research, healthcare delivery, and technological innovation.
Gavin Yin, Founder & CEO of Syrebo, expressed: "It was an honor to showcase our technologies and discuss how we can work together to improve rehabilitation practices globally. The insights shared during this visit will inspire further innovations and partnerships."
This visit highlights the growing global interest in Syrebo's solutions and underscores the importance of international collaboration in advancing rehabilitation science and practice.
About the University of Antwerp
The University of Antwerp is a prestigious academic institution in Belgium, recognized for its excellence in research and education across diverse fields, including health sciences.
About ZAS Hospital
ZAS Hospital is a renowned healthcare institution in Belgium, dedicated to providing exceptional medical care and driving innovation in patient treatment.